Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice

A number of metabolic disorders, including hyperlipidemia, potentially cause chronic kidney disease (CKD), one of their major chronic complications and comorbidities. Rosuvastatin is one of the widely used antiatherogenic drugs among hyperlipidemic patients. Meanwhile, sarpogrelate is not only a 5-h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jingyi, Pei, Zuowei, Yu, Meng, Li, Xiang, Wang, Lu, Lin, Yichen, Chen, Xinyan, Liu, Xiaodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537702/
https://www.ncbi.nlm.nih.gov/pubmed/33029491
http://dx.doi.org/10.1155/2020/1809326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537702/
https://www.ncbi.nlm.nih.gov/pubmed/33029491
http://dx.doi.org/10.1155/2020/1809326

Ejemplares similares